[F2] Flash Talks (Even No.)

9:50 〜 9:51

[F-42] Development of a Novel CRISPR-Cas3-Based Therapeutic Strategy for the Eradication of HBV DNA

*Yoshiki Saiki¹, Kazuto Yoshimi², Masahiko Ito³, Tetsuro Suzuki³, Tomoji Mashimo¹ (1. Department of Animal Genetics, The UTOPIA Center, The University of Tokyo (Japan), 2. Laboratory Animal Science, Graduate School of Medicine and Faculty of Medicine, Kyoto University (Japan), 3. Department of Microbiology and Immunology, Hamamatsu University School of Medicine (Japan))

キーワード：

genome editing、gene therapy、Hepatitis B virus

閲覧にはパスワードが必要です

ログイン

または